News

The study will evaluate the prophylactic use of Camvia in patients undergoing a liver transplant procedure, and will be conducted in up to 60 US transplant centers. The

The placebo controlled trial, conducted at 22 hospitals across Australia, New Zealand and the UK, evaluated the impact of Bronchitol on mucus clearance, disease symptoms, cough severity, exercise

Patients have now progressed into the open-label section of the trial (weeks 24 to 48) and will continue to receive 800mg apricitabine twice a day as part of

The pivotal hylastan trial involved nearly 400 patients with osteoarthritis of the knee enrolled at 27 sites in North America and Europe. Patients were randomized to receive two

The phase I trial is an accelerated titration dose-escalation study designed to assess the safety and tolerability of MP470, and to determine the maximum tolerated dose of the

The company had planned to have the system up and running by late summer. UniChem and AAH Pharmaceuticals were appointed as distribution partners in April. The system replaces

The company said that the decision to end the Lomucin trial was made when it determined that there would be no additional benefit to further enrollment. Genaera plans

The new agreement sets the price for the protease inhibitor at $1,000 per patient per year. Last month, Brazil’s president Luiz Inacio Lula da Silva announced that the

In preclinical studies, PX-478 produced significant tumor regression and growth delay in multiple models of human cancers, including cancers of the lung, breast, prostate, colon, kidney, pancreas and